Trial intelligence / Profile preview

Binaural Beats on Midazolam Requirement During Cesarean Section

NCT07386054Not yet recruiting

Sponsor
Yonsei University
Start
Feb 2026
Primary completion
Jan 2027
01

Overview

Randomised trial (2 arms), sponsored by Yonsei University. Primary endpoint: Total dose of midazolam administered to achieve OAA/S <= 3 at 30 months. Planned start Feb 2026; status: not yet recruiting.

Beyond the preview

Go deeper on NCT07386054.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07386054.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call